Artiva Biotherapeutics halts AlloNK development, cuts staff by 94%Oct 27Quarterly updateArtiva Biotherapeutics, Inc.Biogen
Supernus gets orphan exclusivity for ONAPGO, files sNDA for second supplierOct 21Quarterly updateapomorphineSupernus Pharmaceuticals, Inc.Updated
Serina Therapeutics registers 12.5 million shares for Roth Principal Investments resaleAug 24FinancingSerina Therapeutics
Supernus and Indivior agree to merge as Supernus reports second-quarter growthAug 3Quarterly updateSupernus Pharmaceuticals, Inc.